Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the gold-catalyzed synthesis of 4-polyfluoroalkyl-2,4-disubstituted pyrroles. A high-yield, mild route for reliable pharmaceutical intermediate supply and cost reduction.
Patent CN112138718B introduces a green COF photocatalytic method for biaryl synthesis, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel Ni/C catalyst method for nadifloxacin intermediate. High yield, green process, reliable supply chain partner for pharmaceutical manufacturing.
Novel ionic liquid synthesis for YM-905 intermediate. High yield, low toxicity, scalable production for global supply chains.
Patent CN119431279B reveals a novel Ir-catalyzed asymmetric hydrogenation route for chiral cyclic ethers, offering superior purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN100564362C reveals a streamlined Lewis acid catalyzed route for Azoxystrobin, offering significant cost reduction and supply chain reliability for global agrochemical manufacturers.
Patent CN101712705B details a robust synthetic route for apigenin glycosides, offering reliable supply chain solutions and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN104059952A details immobilized cell catalysis for high-purity intermediates. This method offers significant cost reduction and supply chain reliability for global manufacturers.
Novel copper-palladium catalyzed route for 3-aryl pyrroles. Enhances purity and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Novel bidentate azacarbene manganese catalyst enables mild alkylation. Reduces cost and toxicity in pharmaceutical intermediate manufacturing.
Patent CN108912055B details a catalytic asymmetric dihydroxylation route for antiviral intermediates, offering cost-effective and scalable manufacturing solutions for global supply chains.
Patent CN110903189B details a cost-effective copper-catalyzed route for chiral 2-aryl propionates, offering significant supply chain advantages for NSAID intermediate manufacturing.
Patent CN106380466B details a high-purity cobalt-catalyzed route. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing globally.
Patent CN113429349B details a novel Cu/g-C3N4 catalyzed route for 2-trifluoromethyl benzimidazoles, offering mild conditions and recyclable catalysts for cost-effective manufacturing.
Patent CN113831340B reveals a novel Lewis acid-catalyzed route for calix[n]dihydroacridine macrocycles, offering high yields and simplified purification for electronic chemical manufacturing.
Novel axial and central chirality catalyst enables high enantioselectivity. Reduces costs in pharmaceutical intermediates manufacturing with scalable synthesis.
Patent CN103420901A reveals a green, non-metal catalyzed route to 1,2-dihydropyridines, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN108997247A discloses efficient oxidation route for Rivaroxaban intermediate enabling cost reduction in API manufacturing and supply chain reliability.
Patent CN101163698B reveals efficient Pd-catalyzed coupling and reductive amination routes for 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide, offering significant supply chain advantages.
Patent CN100478333C reveals a novel route for chiral bis-imidazolinylbenzene compounds using amino alcohols, offering cost-effective solutions for asymmetric catalysis ligands.